Brain Metastases News and Research

RSS
Afatinib active against NSCLC nervous system metastases

Afatinib active against NSCLC nervous system metastases

VAL-083 drug compound shows promise against non-small cell lung cancer

VAL-083 drug compound shows promise against non-small cell lung cancer

AZD9291 shows median progression-free survival in patients with EGFRm T790M+ advanced NSCLC

AZD9291 shows median progression-free survival in patients with EGFRm T790M+ advanced NSCLC

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Trastuzumab offers better outcome than lapatinib for HER2-positive breast cancer patients

Alectinib promise for crizotinib-resistant NSCLC

Alectinib promise for crizotinib-resistant NSCLC

AANS, ASTRO partner to launch national registry for SRS treatments

AANS, ASTRO partner to launch national registry for SRS treatments

Stereotactic radiosurgery feasible for multiple brain metastases

Stereotactic radiosurgery feasible for multiple brain metastases

CCC study provides hope that SapC-DOPS could be used for metastatic brain cancer treatment

CCC study provides hope that SapC-DOPS could be used for metastatic brain cancer treatment

Lung cancer and melanoma funders form first-ever research collaboration

Lung cancer and melanoma funders form first-ever research collaboration

Elderly mRCC patients should not be excluded from targeted therapy option

Elderly mRCC patients should not be excluded from targeted therapy option

Key historical misconceptions hinder research and treatment for brain metastases

Key historical misconceptions hinder research and treatment for brain metastases

Angiochem presents data on ANG1005 paclitaxel-peptide drug conjugate at 50th ASCO annual meeting

Angiochem presents data on ANG1005 paclitaxel-peptide drug conjugate at 50th ASCO annual meeting

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

FDA grants Angiochem’s ANG1005 fast track and orphan drug designation for treatment of glioblastoma multiforme

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

Angiochem commences ANG1005 Phase 2 clinical study in HER2+ breast cancer patients with brain metastases

IMPAKT breast cancer conference abstracts online

IMPAKT breast cancer conference abstracts online

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Cell-free DNA analysis allows noninvasive tumour genotype monitoring

Cell-free DNA analysis allows noninvasive tumour genotype monitoring

Neurosurgeons use MRI-guided laser technology to treat deep brain tumor

Neurosurgeons use MRI-guided laser technology to treat deep brain tumor

TGen study reveals genetic origins of breast cancer that spreads to brain

TGen study reveals genetic origins of breast cancer that spreads to brain

Protein may be major culprit when breast cancer metastasizes to the brain

Protein may be major culprit when breast cancer metastasizes to the brain